Today

Agents

Chat

Arena

Discover

More

App

Wedbush raises Denali Therapeutics target price to $24 from $23 - DNLI News | Rallies

Wedbush raises Denali Therapeutics target price to $24 from $23

DNLI•2026-11-04

Wedbush raised its target price for Denali Therapeutics to $24 from $23.

Related News

SJF Bank sees 50% chance of ECB rate hike in December

TLT•2026-11-04

Booking Holdings target price cut to $210 from $247 by Wedbush

BKNG•2026-11-04

Medline Q3 sales rise on customer growth

MDLN•2026-11-04

Xometry: Wedbush raises target price to $140 from $126

XMTR•2026-11-04

Stanley Black & Decker forecasts 2026 adjusted EPS of $5.95-$6.25

SWK•2026-11-04